Strive, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Strive, Inc. on November 14, 2025. The filing addresses a pending all-stock merger transaction between Strive and Semler Scientific, Inc., governed by a Merger Agreement executed on September 22, 2025. The transaction was unanimously approved by the boards of directors of both companies on September 21, 2025.
Key Financial Metrics
This filing does not contain standalone revenue, profit, cash flow, or debt metrics for Strive, Inc. for the current period. Instead, it incorporates by reference:
- Historical financial statements of Semler Scientific for the three and nine months ended September 30, 2025 (Exhibit 99.1).
- Unaudited pro forma combined consolidated financial information for Strive and Semler Scientific (Exhibit 99.2). This data assumes the merger was completed on January 1, 2024, for the statement of operations and September 30, 2025, for the balance sheet.
The filing explicitly states that the pro forma information is for illustrative purposes only and does not project future financial results or indicate actual results had the merger occurred on the specified dates.
Material Changes
The primary material event is the progression of the acquisition of Semler Scientific. The filing updates investors on the availability of Semler's historical financials and the combined pro forma financial data. No other material changes to Strive's standalone operations or financial position are reported in this document.
Guidance, Outlook, and Risks
Management commentary is limited to the strategic intent of the merger and the inclusion of forward-looking statements regarding the transaction's benefits, timing, and integration. The filing includes a comprehensive cautionary statement regarding risks, including:
- Failure of the transaction to close due to unmet conditions or termination rights.
- Integration challenges and diversion of management attention.
- Dilution from the issuance of Strive Class A common stock.
- Risks associated with Bitcoin treasury strategies and digital assets.
- Changes in share prices and potential adverse reactions from customers or employees.
Investors are directed to the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for detailed voting and investment information.
Investor Verification Checklist
- Review the definitive Information Statement/Proxy Statement/Prospectus (Form S-4) for voting details and transaction terms.
- Examine Exhibit 99.1 for Semler Scientific's historical financial performance.
- Analyze Exhibit 99.2 for the unaudited pro forma combined financial position, noting the assumptions and limitations.
- Verify the status of closing conditions and any potential termination events.
- Assess the impact of share dilution resulting from the all-stock acquisition.